Dynavax Technologies Corp Stock
Based on 2 Buy predictions and 1 Sell predictions the sentiment towards Dynavax Technologies Corp is rather balanced.
However, we have a potential of -38.51% for Dynavax Technologies Corp as the target price of 8 € is below the current price of 13.01 €.
Pros and Cons of Dynavax Technologies Corp in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
M***** P*******
?
B****
Cons
?
C******** o* t** e**********
?
S********** s********
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Dynavax Technologies Corp vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Dynavax Technologies Corp | - | - | - | - | - | - | - |
| Heron Therapeutics Inc. | 1.690% | -0.394% | -16.308% | -48.810% | -9.246% | -53.878% | -93.267% |
| Evolus Inc | -1.580% | 1.081% | -8.333% | -72.090% | -31.376% | -54.110% | -59.268% |
| Sangamo Therapeutics Inc. | -2.930% | 14.215% | 18.433% | -60.100% | 5.432% | -86.712% | -96.126% |
Comments
Dynavax Technologies (NASDAQ:DVAX) was upgraded by analysts at Wall Street Zen to a "strong-buy" rating.
Show more
Ratings data for DVAX provided by MarketBeat
Dynavax Technologies (NASDAQ:DVAX) was upgraded by analysts at Wall Street Zen from a "buy" rating to a "strong-buy" rating.
Show more
Ratings data for DVAX provided by MarketBeat
Dynavax Technologies Co. (NASDAQ: DVAX) had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $12.00 to $10.00. They now have a "sell" rating on the stock.
Show more
Ratings data for DVAX provided by MarketBeat
News
Dynavax President and COO Sells 114,000 Shares on Sanofi Acquisition News
David Novack, President & COO of Dynavax Technologies Corporation (NASDAQ:DVAX), exercised 114,000 stock options and immediately sold the resulting shares for a transaction value of approximately
Why Dynavax Stock Soared Today
Shares of Dynavax Technologies (NASDAQ: DVAX) popped on Wednesday after the vaccine maker struck a deal to be acquired by Sanofi (NASDAQ: SNY).
As of 3:00 p.m. EST, Dynavax's stock price was up